Viola Meehan
Patrimonio netto: 563 966 $ in data 30/09/2026
Patrimonio netto: 563 966 $ in data 30/09/2026
Ms. Viola Meehan is on the Board of Directors at Cue Biopharma, Inc. Ms. Meehan was previously employed as a Chief Financial Officer by Vanqua Bio, Inc. and a Vice President by AbbVie, Inc. She received her undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from The University of Chicago.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 09/07/2026 | 21.800 ( 0,3% ) | 563 966 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CUE BIOPHARMA, INC. | Direttore/Membro del Consiglio | 30/05/2026 |
| Società | Posizione | Fine |
|---|---|---|
Vanqua Bio, Inc.
Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Direttore Finanziario/CFO | 01/01/2023 |
| ABBVIE INC. | Corporate Officer/Principal | 01/11/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Vanqua Bio, Inc.
Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale